Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.

Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.

A recent clinical trial in African children demonstrated the potential utility of merozoite surface protein (MSP)-3 as a vaccine against Plasmodium falciparum malaria. The present study evaluated the use of Plasmodium vivax MSP-3 (PvMSP-3) as a target antigen in vaccine formulations against malaria...

Full description

Saved in:
Bibliographic Details
Main Authors: Amanda R Bitencourt, Elaine C Vicentin, Maria C Jimenez, Ricardo Ricci, Juliana A Leite, Fabio T Costa, Luis C Ferreira, Bruce Russell, François Nosten, Laurent Rénia, Mary R Galinski, John W Barnwell, Mauricio M Rodrigues, Irene S Soares
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0056061&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0056061&type=printable

Similar Items